Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro.
Saved in:
| Title: | Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro. |
|---|---|
| Authors: | Cuevas E; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA. Elvis-Yane.Cuevas-Martinez@fda.hhs.gov., Rosas-Hernandez H; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA., Burks SM; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA., Ramirez-Lee MA; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA., Guzman A; Escuela Nacional Preparatoria-UNAM, Mexico, Mexico., Imam SZ; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA., Ali SF; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA., Sarkar S; Division of Neurotoxicology, National Center for Toxicological Research/U.S. Food and Drug Administration, Jefferson, AR, 72079, USA. |
| Source: | Metabolic brain disease [Metab Brain Dis] 2019 Oct; Vol. 34 (5), pp. 1365-1374. Date of Electronic Publication: 2019 Jul 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8610370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7365 (Electronic) Linking ISSN: 08857490 NLM ISO Abbreviation: Metab Brain Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7365 |
|---|---|
| DOI: | 10.1007/s11011-019-00447-8 |
